In March 2017, the FDA finally issued a warning confirming that breast implants cause BIA-ALCL cancer however the history of breast implants causing breast implant associated lymphoma cancer and other cancers goes much farther back.  The first case of lymphoma due to breast implants was reported in 1997, since then and for the past 20 years many cases of BIA-ALCL have occurred and have been reported however there has been a ongoing dismissal and even a concerted coverup of BIA-ALCL and other cancers linked to breast implants by regulators of breast implants, associations of plastic surgeons and plastic surgeons.  Despite the mounting cases of BIA-ALCL and other cancers occurring from breast implants and being reported daily now, manufacturers submitted to the FDA and the FDA approved more textured implants for sale as late as September 23, 2016 knowing that textured implants are particularly linked and responsible for BIA-ALCL.   In fact, the incidence rate for BIA-ALCL for Allergan textured implants (old and new) is approximately 1 in 4,000 from US and Australian studies however other types of implants and smooth implants also cause BIA-ALCL too.  Despite the mounting reports of profound health problems and cancers from breast implants, the FDA is still failing to ensure proper warnings are placed on all breast implants and all breast implant literature to warn women of the cancers associated with breast implants.  Health Canada and the FDA are failing in their duty to the public by failing to ensure warnings are placed on breast implants regarding the cancers they cause.  It should be no surprise that silicone and breast implants cause cancer and profound health problems as silicone is made with several toxic, carcinogenic and endocrine disrupting chemicals which is also hidden from the public by the manufacturers of silicone, the manufacturers of breast implants and by Health Canada and the FDA who approve and govern the sales of breast implants.  

If you have textured implants and or any symptoms of BIA-ALCL you need to push for testing at the time of your explant.  

BIA-ALCL BREAST IMPLANT ASSOCIATED LYMPHOMA is a type of non-Hodgkin’s lymphoma, a cancer of the cells of the immune system (not breast cancer) that can be caused by breast implants.   The main symptoms of BIA-ALCL are persistent swelling or pain in the vicinity of the breast implant, seroma, breast mass, capsular contracture, swollen lymph nodes and usually are associated with textured implants but not in every case.  These symptoms may appear after the implant surgical incision has healed and often can appear years after implant placement.  If you have swelling, pain, seroma, breast mass, capsular contracture or swollen lymph nodes and especially if you have textured implants please push hard for BIA-ALCL testing.  Surgeons should consider the possibility of ALCL when they have a patient with late onset, persistent fluid around the implant (peri-implant seroma) before and or during explant or exhibit the symptoms after explant. When testing for ALCL at the time of explant, surgeons should collect fresh seroma fluid and representative portions of the capsule and send for pathology tests.  The test is called CD-30 Immunochemistry and few plastic surgeons are knowledgeable about BIA-ALCL at this point so it will be up to you to educate your plastic surgeon and persist in getting the test if you have any symptoms and/or textured implants.

Here is the FDA’s recent announcement and information on BIA-ALCL:

Here is the American Society of Plastic Surgeons’ current information on BIA-ALCL:

The following excellent chronology regarding BIA-ALCL was researched and written by Michelle Pastor, Miami, Florida April 2017 and is rather eye opening:

BIA-ALCL Chronology by Michelle Pastor, Miami, Florida April 2017

Needless to say ladies are gathering and organizing and looking into legal and if you are interested to find out further information please join the facebook groups specifically in regard to BIA-ALCL where you can speak with hundreds of other ladies with experience: